The Food and Drug Administration (FDA) has authorized doctors to treat COVID-19 patients with a pair of anti-malaria medications.
Chloroquine and a similar drug, Hydroxychloroquine, have shown encouraging signs in small, early tests against the virus, but they have yet to be studied during a controlled clinical trial.
Both are oral prescription drugs that have been used for the treatment of malaria and certain inflammatory conditions since the 1940s.
Currently, the use of the medications is limited to patients who are currently hospitalized and weigh at least around 110 pounds.
Under the FDA’s emergency authorization, health care providers must contact their local or state health department to access the drugs.